| |
|
| 10 min
|
Business meeting
Cancer SG |
| |
|
| 10 min
|
Business meeting MI
SG |
| |
|
| 5 min
|
Opening, IGDD K.
Farahani (CIP/NCI) |
| |
|
| 15 min
|
Introduction on IGDD
G. Lanza (Washington U.) |
| |
|
| 20 min
|
IGDD in cancer with
MRI- guided Focused Ultrasound N. McDannold
(Harvard) |
| |
|
| 20 min
|
MI aspects of IGDD:
“Monitoring and quantification of drug delivery
using contrast agents” S. Aime (Torino, Italy) |
| |
|
| 10 min
|
Selected abstract MI
SG 2668: G. Kenny et. al., In vivo monitoring of
liposomal encapsulated siRNA delivery to tumours |
| |
|
| 10 min
|
Selected abstract MI
SG 4925: J. Alford et. al., Delta relaxation
enhanced MR: Experimental validation |
| |
|
| 10 min
|
Selected abstract Cancer SG
1993: P. Seevinck et. al., Selective depiction of
holmium-loaded microspheres (HoMS) using susceptibility
gradient mapping (SGM): initial experience in animal
models |
| |
|
| 10 min |
Selected abstract
Cancer SG 3116: S. Genininatti et. al., A Boron/Gd/LDL
adduct for imaging-guided Neutron Capture Therapy |
| |
|